Infectious Diseases Institute
The key goal of the research programme at IDI is to produce outstanding internationally recognized scholarship on HIV and related infectious diseases that informs policy, training and practice in Africa.
IDI seeks to develop a research programme with projects which are largely IDI-initiated and IDI-led, which are focused on issues relevant to Africa, and which generate high quality research outputs which are used in Africa to improve training and policies / guidelines for prevention, care and treatment. Current IDI research priorities are:
- HIV treatment failure & resistance
- HIV-related malignancies
- Complications of ARVs
- Meningitis in HIV
- Clinical Pharmacology for ID
- HIV Neurology
- Sexual and Reproductive Health
- HIV/OI prevention
- Socio-behavioral research on HIV/AIDS
Within the EACCR, IDI seeks to contribute towards research capacity building in areas where it has strengths (include short GCP training modules in HIV research), while at the same time benefit from the network in areas that need strengthening at IDI. IDI will also seek research collaborations within the network to address research areas of common interest.
IDI is part of several international and regional networks including the NIH-funded International Epidemiological Databases to Evaluate AIDS (IEDEA) the Canada - Africa Prevention Trials Network (CAPTN), East African Clinical Trials Partnership (EACTP), European and Developing Countries Clinical Trials Partnerships (EDCTP), TB Vaccine Alliance, and the Infectious Diseases Network for Treatment and Research in Africa (INTERACT), among others.
IDI has about 250 research staff.
The IDI Research Trainees:
The IDI building:
IDI Building, Mulago Hospital Complex, Mulago Hill